Joint Annual Interagency Coordination Report, FY2024 (Texas Government Code 531.103)

Joint Interagency Coordination Report, fiscal year 2024 (6 pp.): coordination activities; OIG and MFCU key metrics and significant OIG/MFCU cases (out of scope); Healthcare Program Enforcement Division (formerly Civil Medicaid Fraud) table (cases opened 64, closed 117, pending 351, recovered $43,711,128); two significant HPED settlements; ongoing cases (Pfizer/Tris, Regeneron, Medical Diagnostic Laboratories, Gilead, LabCorp) without amounts. Recovery total already recorded. Added the three case counts and the Bayer settlement (relator portion) as a case. Not added as a case: Pathology Reference Laboratory ($4.2 million, state and federal portions only). Decision 10 pass (2026-10-10): every named settlement, judgment and newly announced government suit not already in cases.csv added as a case with whistleblower_link=not_stated (the document does not tie it to a whistleblower): 2 cases (1 settlements, 1 pending government suits or claims). Amounts as printed (lower/upper bounds and global vs civil parts explained in notes); individuals only where named by the agency as parties. Added Pathology Reference Laboratory ($4.2 million, state and federal portions only) and the first appearance of the Regeneron case; the OIG administrative settlements (unnamed initiatives and a pharmacy) and MFCU criminal restitution remain out of scope, and the other ongoing cases repeat earlier reports.